TP53 and neoplasm: Using immunohistochemistry, Abudu et al. (1999) detected TP53 over-expression indicative of non-functional protein in 14% of tumor samples (N = 7/52) and this over-expression was associated with advanced disease at diagnosis, poorer treatment response, and a worse overall survival.